Hydracarbazine

DB09243

small molecule experimental

Deskripsi

Hydracarbazine is a pyridazine that has found use as an antihypertensive agent A19790 It was once marketed in France under the tradename Normatensyl.

Struktur Molekul 2D

Berat 153.145
Wujud solid

Peta Jejaring Molekuler
Legenda: ObatTargetGenEnzim(Panah → menunjukkan arah efek / relasi)TransporterCarrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) -
Volume Distribusi -
Klirens (Clearance) -

Absorpsi

Data absorpsi tidak tersedia.

Metabolisme

Data metabolisme tidak tersedia.

Rute Eliminasi

Data eliminasi belum tersedia.

Interaksi Obat

1322 Data
Doxylamine Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Hydracarbazine.
Dronabinol Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Hydracarbazine.
Droperidol Droperidol may increase the central nervous system depressant (CNS depressant) activities of Hydracarbazine.
Hydroxyzine Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Hydracarbazine.
Magnesium sulfate The therapeutic efficacy of Hydracarbazine can be increased when used in combination with Magnesium sulfate.
Methotrimeprazine Hydracarbazine may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine.
Metyrosine Hydracarbazine may increase the sedative activities of Metyrosine.
Minocycline Minocycline may increase the central nervous system depressant (CNS depressant) activities of Hydracarbazine.
Nabilone Nabilone may increase the central nervous system depressant (CNS depressant) activities of Hydracarbazine.
Orphenadrine Hydracarbazine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.
Paraldehyde Hydracarbazine may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.
Perampanel Perampanel may increase the central nervous system depressant (CNS depressant) activities of Hydracarbazine.
Pramipexole Hydracarbazine may increase the sedative activities of Pramipexole.
Ropinirole Hydracarbazine may increase the sedative activities of Ropinirole.
Rotigotine Hydracarbazine may increase the sedative activities of Rotigotine.
Rufinamide The risk or severity of adverse effects can be increased when Rufinamide is combined with Hydracarbazine.
Sodium oxybate Hydracarbazine may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.
Suvorexant Hydracarbazine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.
Thalidomide Hydracarbazine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Zolpidem Hydracarbazine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.
Desmopressin The risk or severity of hypertension can be increased when Desmopressin is combined with Hydracarbazine.
Cyclosporine The risk or severity of hypertension can be increased when Cyclosporine is combined with Hydracarbazine.
Icosapent The risk or severity of hypertension can be increased when Icosapent is combined with Hydracarbazine.
Mesalazine The risk or severity of hypertension can be increased when Mesalazine is combined with Hydracarbazine.
Indomethacin The risk or severity of hypertension can be increased when Indomethacin is combined with Hydracarbazine.
Methylergometrine The risk or severity of hypertension can be increased when Methylergometrine is combined with Hydracarbazine.
Nabumetone The risk or severity of hypertension can be increased when Nabumetone is combined with Hydracarbazine.
Ketorolac The risk or severity of hypertension can be increased when Ketorolac is combined with Hydracarbazine.
Tenoxicam The risk or severity of hypertension can be increased when Tenoxicam is combined with Hydracarbazine.
Celecoxib The risk or severity of hypertension can be increased when Celecoxib is combined with Hydracarbazine.
Tolmetin The risk or severity of hypertension can be increased when Tolmetin is combined with Hydracarbazine.
Rofecoxib The risk or severity of hypertension can be increased when Rofecoxib is combined with Hydracarbazine.
Piroxicam The risk or severity of hypertension can be increased when Piroxicam is combined with Hydracarbazine.
Fenoprofen The risk or severity of hypertension can be increased when Fenoprofen is combined with Hydracarbazine.
Valdecoxib The risk or severity of hypertension can be increased when Valdecoxib is combined with Hydracarbazine.
Diclofenac The risk or severity of hypertension can be increased when Diclofenac is combined with Hydracarbazine.
Sulindac The risk or severity of hypertension can be increased when Sulindac is combined with Hydracarbazine.
Nicergoline The risk or severity of hypertension can be increased when Nicergoline is combined with Hydracarbazine.
Flurbiprofen The risk or severity of hypertension can be increased when Flurbiprofen is combined with Hydracarbazine.
Etodolac The risk or severity of hypertension can be increased when Etodolac is combined with Hydracarbazine.
Mefenamic acid The risk or severity of hypertension can be increased when Mefenamic acid is combined with Hydracarbazine.
Naproxen The risk or severity of hypertension can be increased when Naproxen is combined with Hydracarbazine.
Sulfasalazine The risk or severity of hypertension can be increased when Sulfasalazine is combined with Hydracarbazine.
Phenylbutazone The risk or severity of hypertension can be increased when Phenylbutazone is combined with Hydracarbazine.
Meloxicam The risk or severity of hypertension can be increased when Meloxicam is combined with Hydracarbazine.
Carprofen The risk or severity of hypertension can be increased when Carprofen is combined with Hydracarbazine.
Phenmetrazine The risk or severity of hypertension can be increased when Phenmetrazine is combined with Hydracarbazine.
Diflunisal The risk or severity of hypertension can be increased when Diflunisal is combined with Hydracarbazine.
Salicylic acid The risk or severity of hypertension can be increased when Salicylic acid is combined with Hydracarbazine.
Meclofenamic acid The risk or severity of hypertension can be increased when Meclofenamic acid is combined with Hydracarbazine.
Dopamine The risk or severity of hypertension can be increased when Dopamine is combined with Hydracarbazine.
Oxaprozin The risk or severity of hypertension can be increased when Oxaprozin is combined with Hydracarbazine.
Ketoprofen The risk or severity of hypertension can be increased when Ketoprofen is combined with Hydracarbazine.
Balsalazide The risk or severity of hypertension can be increased when Balsalazide is combined with Hydracarbazine.
Ibuprofen The risk or severity of hypertension can be increased when Ibuprofen is combined with Hydracarbazine.
Dutasteride The risk or severity of hypertension can be increased when Dutasteride is combined with Hydracarbazine.
Propafenone The risk or severity of hypertension can be increased when Propafenone is combined with Hydracarbazine.
Finasteride The risk or severity of hypertension can be increased when Finasteride is combined with Hydracarbazine.
Lumiracoxib The risk or severity of hypertension can be increased when Lumiracoxib is combined with Hydracarbazine.
Ephedrine The risk or severity of hypertension can be increased when Ephedrine is combined with Hydracarbazine.
Magnesium salicylate The risk or severity of hypertension can be increased when Magnesium salicylate is combined with Hydracarbazine.
Salsalate The risk or severity of hypertension can be increased when Salsalate is combined with Hydracarbazine.
Choline magnesium trisalicylate The risk or severity of hypertension can be increased when Choline magnesium trisalicylate is combined with Hydracarbazine.
Antrafenine The risk or severity of hypertension can be increased when Antrafenine is combined with Hydracarbazine.
Aminophenazone The risk or severity of hypertension can be increased when Aminophenazone is combined with Hydracarbazine.
Antipyrine The risk or severity of hypertension can be increased when Antipyrine is combined with Hydracarbazine.
Tiaprofenic acid The risk or severity of hypertension can be increased when Tiaprofenic acid is combined with Hydracarbazine.
Etoricoxib The risk or severity of hypertension can be increased when Etoricoxib is combined with Hydracarbazine.
Epicaptopril The risk or severity of hypertension can be increased when Epicaptopril is combined with Hydracarbazine.
Taxifolin The risk or severity of hypertension can be increased when Taxifolin is combined with Hydracarbazine.
Oxyphenbutazone The risk or severity of hypertension can be increased when Oxyphenbutazone is combined with Hydracarbazine.
1-benzylimidazole The risk or severity of hypertension can be increased when 1-benzylimidazole is combined with Hydracarbazine.
Benoxaprofen The risk or severity of hypertension can be increased when Benoxaprofen is combined with Hydracarbazine.
Metamizole The risk or severity of hypertension can be increased when Metamizole is combined with Hydracarbazine.
Zomepirac The risk or severity of hypertension can be increased when Zomepirac is combined with Hydracarbazine.
Dronedarone The risk or severity of hypertension can be increased when Dronedarone is combined with Hydracarbazine.
Cimicoxib The risk or severity of hypertension can be increased when Cimicoxib is combined with Hydracarbazine.
Amibegron The risk or severity of hypertension can be increased when Amibegron is combined with Hydracarbazine.
Nylidrin The risk or severity of hypertension can be increased when Nylidrin is combined with Hydracarbazine.
Solabegron The risk or severity of hypertension can be increased when Solabegron is combined with Hydracarbazine.
Lornoxicam The risk or severity of hypertension can be increased when Lornoxicam is combined with Hydracarbazine.
Aceclofenac The risk or severity of hypertension can be increased when Aceclofenac is combined with Hydracarbazine.
Zaltoprofen The risk or severity of hypertension can be increased when Zaltoprofen is combined with Hydracarbazine.
Saralasin The risk or severity of hypertension can be increased when Saralasin is combined with Hydracarbazine.
Azapropazone The risk or severity of hypertension can be increased when Azapropazone is combined with Hydracarbazine.
Parecoxib The risk or severity of hypertension can be increased when Parecoxib is combined with Hydracarbazine.
Salicylamide The risk or severity of hypertension can be increased when Salicylamide is combined with Hydracarbazine.
Tyramine The risk or severity of hypertension can be increased when Tyramine is combined with Hydracarbazine.
Mirabegron The risk or severity of hypertension can be increased when Mirabegron is combined with Hydracarbazine.
Adrafinil The risk or severity of hypertension can be increased when Adrafinil is combined with Hydracarbazine.
Kebuzone The risk or severity of hypertension can be increased when Kebuzone is combined with Hydracarbazine.
Isoxicam The risk or severity of hypertension can be increased when Isoxicam is combined with Hydracarbazine.
Indoprofen The risk or severity of hypertension can be increased when Indoprofen is combined with Hydracarbazine.
Ibuproxam The risk or severity of hypertension can be increased when Ibuproxam is combined with Hydracarbazine.
Floctafenine The risk or severity of hypertension can be increased when Floctafenine is combined with Hydracarbazine.
Fenbufen The risk or severity of hypertension can be increased when Fenbufen is combined with Hydracarbazine.
Etofenamate The risk or severity of hypertension can be increased when Etofenamate is combined with Hydracarbazine.
Etilefrine The risk or severity of hypertension can be increased when Etilefrine is combined with Hydracarbazine.
Epirizole The risk or severity of hypertension can be increased when Epirizole is combined with Hydracarbazine.
Benzydamine The risk or severity of hypertension can be increased when Benzydamine is combined with Hydracarbazine.

Referensi & Sumber

Artikel (PubMed)
  • PMID: -
    Francis JE: Antihypertensives acting by a peripheral mechanism ACS Symposium Series. 1976 June 01;27:55-79.
Textbook
  • ISBN: 978-0-7020-3471-8
    22. (2012). In Rang and Dale's Pharmacology (7th ed., pp. 273). Edinburgh: Elsevier/Churchill Livingstone.

Contoh Produk & Brand

Produk: 0 • International brands: 0
Belum ada data produk/brand untuk obat ini pada database. Jalankan import DrugBank untuk mengisi field produk/brand.

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul